Search company, investor...
Airsonett company logo



Unattributed VC - II | Alive

Total Raised


Last Raised

$1.6M | 4 mos ago

About Airsonett

Airsonett develops medical devices for the non-pharmacologic treatment of allergic severe asthma and eczema. The company's Airsonett Air4 is a non-invasive device for treatment in the home, based on the patented Temperature-controlled Laminar Airflow technology (TLA). Treatment with the Airsonett Air4 reduces allergens and other airborne irritants from the patient’s breathing zone during rest and sleep. Airsonett is based in Angelholm, Sweden.

Headquarters Location

Kelliehousevägen 31

Angelholm, 26274,


Missing: Airsonett's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Airsonett's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Airsonett Patents

Airsonett has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Diabetes, Air pollution, Syndromes, Intensive care medicine, Inflammations


Application Date


Grant Date



Related Topics

Diabetes, Air pollution, Syndromes, Intensive care medicine, Inflammations



Latest Airsonett News

18D7E0DE-2035-40AE-A740-8F45A358A8F4 D022C0CB-74A1-418A-B63C-520A9426F5D4@3x 17078B2A-823B-4986-9396-4716961A6828@3x Vinge advises Stiftelsen Industrifonden on the investment in Airsonett AB

Aug 15, 2022

August 23, 2007 Industrifonden and SEB will make a joint investment of MSEK 55 and the existing shareholders will invest the remaining MSEK 15 in Airsonett AB, a medical technology company. Airsonett AB carries out research and develops non-pharmaceutical aids reducing the allergen and other air pollution. Stiftelsen Industrifonden is represented by partner Johan Winnerblad and Johan Larsson. August 10, 2022 July 26, 2022 On 17 June 2022, the Council adopted a regulation on a new instrument for international procurement (“IPI”), following the formal adoption of the IPI at the European Parliament plenary session on 9 June 2022. The general objective of the IPI is to create reciprocity in the access to international public procurement markets by enabling the Commission to undertake investigations and adopt measures to open and improve access to third-country public procurement and concession markets. July 11, 2022 Vinge is a full service business law firm with leading expertise within all areas of business law. We are a total of 500 co‑workers at our offices in Stockholm, Gothenburg, Malmö, Helsingborg and Brussels. Follow us

Airsonett Frequently Asked Questions (FAQ)

  • Where is Airsonett's headquarters?

    Airsonett's headquarters is located at Kelliehousevägen 31, Angelholm.

  • What is Airsonett's latest funding round?

    Airsonett's latest funding round is Unattributed VC - II.

  • How much did Airsonett raise?

    Airsonett raised a total of $8.6M.

  • Who are the investors of Airsonett?

    Investors of Airsonett include FSG Fond, Industrifonden and SEB Venture Capital.

  • Who are Airsonett's competitors?

    Competitors of Airsonett include Affectiva, Bioness, Cagenix, Magneceutical Health, Freedom Scientific and 9 more.

Compare Airsonett to Competitors

Assay Designs

Assay Designs aims to provide the worldwide biomedical, pharmaceutical, and scientific research communities with quality, rapid, and easy-to-use products designed to "Simplify Your Science".

Autochair Logo

Autochair specialises in the design and manufacture of hoists and other aids to assist people with disabilities and reduced mobility.


Celula is a diagnostic testing services company focused on significantly improving the accuracy of diagnosing major diseases, enabling better patient care and improved outcomes. Celula's unique cost effective "Integrated Diagnostic Accuracy" platform (IDA) consists of algorithmically combining proprietary technologies and non-proprietary technologies that together achieve significantly greater accuracy compared to current tests. The company's initial products will focus on improving the diagnostic accuracy of major women's diseases, specifically in gynecologic cancers and non-invasive prenatal diagnosis. Celula has an established infrastructure in both the U.S. and China allowing it to develop new products in a significantly more capital efficient manner as well as expand its commercial opportunities beyond the U.S.


Lumineyes uses a laser to heat the pigment layer of their eye to allow people with brown eyes to turn them permanently green or blue.

Abilities MedTec

Abilities MedTec manufactures and distributes durable medical equipment (DME) in the United States. The product is a multi-lifting device that aims to provide people with mobility beyond their wheelchair. Per the company, the same lift can also transfer equipment such as scooters and power chairs.

eSight Logo

eSight creates electronic glasses that restore or enhance sight for individuals living with vision loss. Worn comfortably like a normal pair of glasses or with prescription lenses built-in, they allow a person with low vision to see in virtually the same manner as someone who is fully-sighted can. The company's SPEX enhances vision for precision tasks, allowing users to pan and zoom the real world or streamed images, and brings critical information to the point of task without overwriting or obstructing natural vision for full situational awareness and mobility.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.